Management and operation of a biocontainment laboratory for infectious diseases
Official title: Facility Management, Maintenance and Operation Core
Funded at Colorado State University · NIH-10910198 · Data updated 2026-11-12
This study looks at how to keep a special lab running smoothly and safely so that researchers can work on dangerous germs, like those that cause COVID-19 and tuberculosis, which could help create better treatments and vaccines for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $1,493,669 |
| NIH project number | 5UC7AI180308-02 |
| Project ID | NIH-10910198 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals affected by infectious diseases or those at risk of exposure to emerging pathogens.
✕Less likely to help
Patients with non-infectious diseases or those not at risk of exposure to infectious pathogens may not receive direct benefits from this research.
What this research studies
This research focuses on the management and operation of the BSL3 suites at the Rocky Mountain Regional Biocontainment Laboratory at Colorado State University. These facilities are essential for conducting research on high-risk pathogens, including those that can cause severe diseases like COVID-19 and tuberculosis. The laboratory aims to ensure readiness and rapid response to emerging infectious diseases by maintaining operational efficiency and safety standards. Patients may benefit indirectly through advancements in treatments and vaccines developed from the research conducted in these facilities.
Why it matters
Potential benefit: If successful, this research could lead to improved responses to infectious disease outbreaks, ultimately enhancing patient care and public health safety.
How similar studies have gone: Other research facilities have successfully operated under similar models, demonstrating the effectiveness of biocontainment laboratories in managing infectious disease threats.
Where this research is happening
-
Colorado State University
Fort Collins, United States Active
Researchers
- Principal investigator: Goodrich, Raymond Paul — Colorado State University
- Study coordinator: Goodrich, Raymond Paul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.